Status:
COMPLETED
Medication Reviews in Severe Mental Illness
Lead Sponsor:
Psychiatric Research Unit, Region Zealand, Denmark
Collaborating Sponsors:
Steno Diabetes Center Sjaelland
Region Zealand
Conditions:
Schizophrenia
Diabetes
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study aims to investigate the potential beneficial effects of a medication review by a clinical pharmacologist on patients with coexisting severe mental illness and diabetes. The study is an inte...
Detailed Description
The effects of a medication review on patients with coexisting severe mental illness and diabetes: Introduction: Severe mental illness (SMI) is associated with an increased risk of diabetes (DM) and...
Eligibility Criteria
Inclusion
- The patients drafted must have diabetes (unspecified) and severe mental illness in this case schizophrenia, severe ADHD, anxiety, any other psychotic disorders or an affective disorder (e.g. bipolar disease and major depression). Patients are drafted from the "fusion clinic" in Slagelse Denmark which is a collaboration between endocrinologists and psychiatrists in the joint treatment of patients with diabetes and mental illness.
- Only adult patients
Exclusion
- none of the above
- Pediatric patients
Key Trial Info
Start Date :
March 11 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 27 2023
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT05243160
Start Date
March 11 2022
End Date
October 27 2023
Last Update
September 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Unit for Psychotherapy and Psychopathology
Slagelse, Denmark, 4200